IBDEI0H7 ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23140,1,5,0)
 ;;=5^Hemolytic Anem, Heredit
 ;;^UTILITY(U,$J,358.3,23140,2)
 ;;=^56578
 ;;^UTILITY(U,$J,358.3,23141,0)
 ;;=283.19^^152^1369^70
 ;;^UTILITY(U,$J,358.3,23141,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23141,1,4,0)
 ;;=4^283.19
 ;;^UTILITY(U,$J,358.3,23141,1,5,0)
 ;;=5^Hemolytic Anemia, Microang
 ;;^UTILITY(U,$J,358.3,23141,2)
 ;;=^293664
 ;;^UTILITY(U,$J,358.3,23142,0)
 ;;=280.9^^152^1369^74
 ;;^UTILITY(U,$J,358.3,23142,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23142,1,4,0)
 ;;=4^280.9
 ;;^UTILITY(U,$J,358.3,23142,1,5,0)
 ;;=5^Iron Defic Anemia(Unspecified)
 ;;^UTILITY(U,$J,358.3,23142,2)
 ;;=^276946
 ;;^UTILITY(U,$J,358.3,23143,0)
 ;;=285.1^^152^1369^72
 ;;^UTILITY(U,$J,358.3,23143,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23143,1,4,0)
 ;;=4^285.1
 ;;^UTILITY(U,$J,358.3,23143,1,5,0)
 ;;=5^Iron Defic Anemia Due To Acute Blood Loss
 ;;^UTILITY(U,$J,358.3,23143,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,23144,0)
 ;;=280.0^^152^1369^73
 ;;^UTILITY(U,$J,358.3,23144,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23144,1,4,0)
 ;;=4^280.0
 ;;^UTILITY(U,$J,358.3,23144,1,5,0)
 ;;=5^Iron Defic Anemia Due To Chronic Blood Loss
 ;;^UTILITY(U,$J,358.3,23144,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,23145,0)
 ;;=281.9^^152^1369^92
 ;;^UTILITY(U,$J,358.3,23145,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23145,1,4,0)
 ;;=4^281.9
 ;;^UTILITY(U,$J,358.3,23145,1,5,0)
 ;;=5^Nutritional Anemia
 ;;^UTILITY(U,$J,358.3,23145,2)
 ;;=^123801
 ;;^UTILITY(U,$J,358.3,23146,0)
 ;;=281.0^^152^1369^109
 ;;^UTILITY(U,$J,358.3,23146,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23146,1,4,0)
 ;;=4^281.0
 ;;^UTILITY(U,$J,358.3,23146,1,5,0)
 ;;=5^Vit B12 Deficiency (Pernicious Anemia)
 ;;^UTILITY(U,$J,358.3,23146,2)
 ;;=^7161
 ;;^UTILITY(U,$J,358.3,23147,0)
 ;;=282.60^^152^1369^99
 ;;^UTILITY(U,$J,358.3,23147,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23147,1,4,0)
 ;;=4^282.60
 ;;^UTILITY(U,$J,358.3,23147,1,5,0)
 ;;=5^Sickle-Cell Anemia
 ;;^UTILITY(U,$J,358.3,23147,2)
 ;;=^7188
 ;;^UTILITY(U,$J,358.3,23148,0)
 ;;=282.62^^152^1369^100
 ;;^UTILITY(U,$J,358.3,23148,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23148,1,4,0)
 ;;=4^282.62
 ;;^UTILITY(U,$J,358.3,23148,1,5,0)
 ;;=5^Sickle-Cell With Crisis
 ;;^UTILITY(U,$J,358.3,23148,2)
 ;;=^267982
 ;;^UTILITY(U,$J,358.3,23149,0)
 ;;=281.1^^152^1369^110
 ;;^UTILITY(U,$J,358.3,23149,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23149,1,4,0)
 ;;=4^281.1
 ;;^UTILITY(U,$J,358.3,23149,1,5,0)
 ;;=5^Vit B12 Deficiency(Dietary)
 ;;^UTILITY(U,$J,358.3,23149,2)
 ;;=^267974
 ;;^UTILITY(U,$J,358.3,23150,0)
 ;;=286.7^^152^1369^44
 ;;^UTILITY(U,$J,358.3,23150,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23150,1,4,0)
 ;;=4^286.7
 ;;^UTILITY(U,$J,358.3,23150,1,5,0)
 ;;=5^Coagulation Defect(Any),Acquired
 ;;^UTILITY(U,$J,358.3,23150,2)
 ;;=^2235
 ;;^UTILITY(U,$J,358.3,23151,0)
 ;;=289.9^^152^1369^106
 ;;^UTILITY(U,$J,358.3,23151,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23151,1,4,0)
 ;;=4^289.9
 ;;^UTILITY(U,$J,358.3,23151,1,5,0)
 ;;=5^Thrombocytosis, Essential
 ;;^UTILITY(U,$J,358.3,23151,2)
 ;;=^55344
 ;;^UTILITY(U,$J,358.3,23152,0)
 ;;=451.9^^152^1369^107
 ;;^UTILITY(U,$J,358.3,23152,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23152,1,4,0)
 ;;=4^451.9
 ;;^UTILITY(U,$J,358.3,23152,1,5,0)
 ;;=5^Thrombophlebitis 
 ;;^UTILITY(U,$J,358.3,23152,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,23153,0)
 ;;=446.6^^152^1369^108
 ;;^UTILITY(U,$J,358.3,23153,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23153,1,4,0)
 ;;=4^446.6
 ;;^UTILITY(U,$J,358.3,23153,1,5,0)
 ;;=5^Thrombotic Thrombocytopenic Purpura(Ttp)
 ;;^UTILITY(U,$J,358.3,23153,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,23154,0)
 ;;=286.4^^152^1369^111
 ;;^UTILITY(U,$J,358.3,23154,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23154,1,4,0)
 ;;=4^286.4
 ;;^UTILITY(U,$J,358.3,23154,1,5,0)
 ;;=5^Von Willebrand'S Disease
 ;;^UTILITY(U,$J,358.3,23154,2)
 ;;=^127267
 ;;^UTILITY(U,$J,358.3,23155,0)
 ;;=204.00^^152^1369^4
 ;;^UTILITY(U,$J,358.3,23155,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23155,1,4,0)
 ;;=4^204.00
 ;;^UTILITY(U,$J,358.3,23155,1,5,0)
 ;;=5^All, W/O Remission
 ;;^UTILITY(U,$J,358.3,23155,2)
 ;;=^267521
 ;;^UTILITY(U,$J,358.3,23156,0)
 ;;=204.01^^152^1369^3
 ;;^UTILITY(U,$J,358.3,23156,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23156,1,4,0)
 ;;=4^204.01
 ;;^UTILITY(U,$J,358.3,23156,1,5,0)
 ;;=5^All, In Remission
 ;;^UTILITY(U,$J,358.3,23156,2)
 ;;=^267522
 ;;^UTILITY(U,$J,358.3,23157,0)
 ;;=204.10^^152^1369^41
 ;;^UTILITY(U,$J,358.3,23157,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23157,1,4,0)
 ;;=4^204.10
 ;;^UTILITY(U,$J,358.3,23157,1,5,0)
 ;;=5^Cll, W/O Remission
 ;;^UTILITY(U,$J,358.3,23157,2)
 ;;=^267523
 ;;^UTILITY(U,$J,358.3,23158,0)
 ;;=204.11^^152^1369^40
 ;;^UTILITY(U,$J,358.3,23158,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23158,1,4,0)
 ;;=4^204.11
 ;;^UTILITY(U,$J,358.3,23158,1,5,0)
 ;;=5^Cll, In Remission
 ;;^UTILITY(U,$J,358.3,23158,2)
 ;;=^267524
 ;;^UTILITY(U,$J,358.3,23159,0)
 ;;=201.90^^152^1369^71
 ;;^UTILITY(U,$J,358.3,23159,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23159,1,4,0)
 ;;=4^201.90
 ;;^UTILITY(U,$J,358.3,23159,1,5,0)
 ;;=5^Hodgkin'S Lymphoma, Unpsec Type & Site
 ;;^UTILITY(U,$J,358.3,23159,2)
 ;;=^267430
 ;;^UTILITY(U,$J,358.3,23160,0)
 ;;=785.6^^152^1369^77
 ;;^UTILITY(U,$J,358.3,23160,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23160,1,4,0)
 ;;=4^785.6
 ;;^UTILITY(U,$J,358.3,23160,1,5,0)
 ;;=5^Lymphadenopathy
 ;;^UTILITY(U,$J,358.3,23160,2)
 ;;=^72368
 ;;^UTILITY(U,$J,358.3,23161,0)
 ;;=200.20^^152^1369^78
 ;;^UTILITY(U,$J,358.3,23161,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23161,1,4,0)
 ;;=4^200.20
 ;;^UTILITY(U,$J,358.3,23161,1,5,0)
 ;;=5^Lymphoma, Burkitt'S, Unspecified Sites
 ;;^UTILITY(U,$J,358.3,23161,2)
 ;;=^17529
 ;;^UTILITY(U,$J,358.3,23162,0)
 ;;=202.00^^152^1369^80
 ;;^UTILITY(U,$J,358.3,23162,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23162,1,4,0)
 ;;=4^202.00
 ;;^UTILITY(U,$J,358.3,23162,1,5,0)
 ;;=5^Lymphoma, Low-Grade, Unspec Site
 ;;^UTILITY(U,$J,358.3,23162,2)
 ;;=^72606
 ;;^UTILITY(U,$J,358.3,23163,0)
 ;;=200.10^^152^1369^79
 ;;^UTILITY(U,$J,358.3,23163,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23163,1,4,0)
 ;;=4^200.10
 ;;^UTILITY(U,$J,358.3,23163,1,5,0)
 ;;=5^Lymphoma, Int Or High Grade, Unspec Site
 ;;^UTILITY(U,$J,358.3,23163,2)
 ;;=^175886
 ;;^UTILITY(U,$J,358.3,23164,0)
 ;;=273.3^^152^1369^81
 ;;^UTILITY(U,$J,358.3,23164,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23164,1,4,0)
 ;;=4^273.3
 ;;^UTILITY(U,$J,358.3,23164,1,5,0)
 ;;=5^Macroglobulinemia
 ;;^UTILITY(U,$J,358.3,23164,2)
 ;;=^73013
 ;;^UTILITY(U,$J,358.3,23165,0)
 ;;=203.00^^152^1369^90
 ;;^UTILITY(U,$J,358.3,23165,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23165,1,4,0)
 ;;=4^203.00
 ;;^UTILITY(U,$J,358.3,23165,1,5,0)
 ;;=5^Multiple Myeloma W/O Rem
 ;;^UTILITY(U,$J,358.3,23165,2)
 ;;=^267514
 ;;^UTILITY(U,$J,358.3,23166,0)
 ;;=203.01^^152^1369^89
 ;;^UTILITY(U,$J,358.3,23166,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23166,1,4,0)
 ;;=4^203.01
 ;;^UTILITY(U,$J,358.3,23166,1,5,0)
 ;;=5^Multiple Myeloma In Remission
 ;;^UTILITY(U,$J,358.3,23166,2)
 ;;=^267515
 ;;^UTILITY(U,$J,358.3,23167,0)
 ;;=238.6^^152^1369^93
 ;;^UTILITY(U,$J,358.3,23167,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23167,1,4,0)
 ;;=4^238.6
 ;;^UTILITY(U,$J,358.3,23167,1,5,0)
 ;;=5^Plasmacytoma Nos
 ;;^UTILITY(U,$J,358.3,23167,2)
 ;;=^81973
 ;;^UTILITY(U,$J,358.3,23168,0)
 ;;=205.00^^152^1369^6
 ;;^UTILITY(U,$J,358.3,23168,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23168,1,4,0)
 ;;=4^205.00
 ;;^UTILITY(U,$J,358.3,23168,1,5,0)
 ;;=5^Aml, W/O Remission
 ;;^UTILITY(U,$J,358.3,23168,2)
 ;;=^267531
 ;;^UTILITY(U,$J,358.3,23169,0)
 ;;=205.01^^152^1369^5
 ;;^UTILITY(U,$J,358.3,23169,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23169,1,4,0)
 ;;=4^205.01
 ;;^UTILITY(U,$J,358.3,23169,1,5,0)
 ;;=5^Aml, In Remission
 ;;^UTILITY(U,$J,358.3,23169,2)
 ;;=^267532
 ;;^UTILITY(U,$J,358.3,23170,0)
 ;;=205.10^^152^1369^43
 ;;^UTILITY(U,$J,358.3,23170,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23170,1,4,0)
 ;;=4^205.10
 ;;^UTILITY(U,$J,358.3,23170,1,5,0)
 ;;=5^Cml, W/O Remission
 ;;^UTILITY(U,$J,358.3,23170,2)
 ;;=^267533
 ;;^UTILITY(U,$J,358.3,23171,0)
 ;;=205.11^^152^1369^42
 ;;^UTILITY(U,$J,358.3,23171,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23171,1,4,0)
 ;;=4^205.11
 ;;^UTILITY(U,$J,358.3,23171,1,5,0)
 ;;=5^Cml, In Remission
 ;;^UTILITY(U,$J,358.3,23171,2)
 ;;=^267534
 ;;^UTILITY(U,$J,358.3,23172,0)
 ;;=289.0^^152^1369^45
 ;;^UTILITY(U,$J,358.3,23172,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23172,1,4,0)
 ;;=4^289.0
 ;;^UTILITY(U,$J,358.3,23172,1,5,0)
 ;;=5^Erthryocytosis, Secondary
 ;;^UTILITY(U,$J,358.3,23172,2)
 ;;=^186856
 ;;^UTILITY(U,$J,358.3,23173,0)
 ;;=238.4^^152^1369^94
 ;;^UTILITY(U,$J,358.3,23173,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23173,1,4,0)
 ;;=4^238.4
 ;;^UTILITY(U,$J,358.3,23173,1,5,0)
 ;;=5^Polycytheria Rubra Vera
 ;;^UTILITY(U,$J,358.3,23173,2)
 ;;=^96105
 ;;^UTILITY(U,$J,358.3,23174,0)
 ;;=V58.61^^152^1369^112
 ;;^UTILITY(U,$J,358.3,23174,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23174,1,4,0)
 ;;=4^V58.61
 ;;^UTILITY(U,$J,358.3,23174,1,5,0)
 ;;=5^Warfarin/Coumadin Use
 ;;^UTILITY(U,$J,358.3,23174,2)
 ;;=Warfarin/Coumadin Use^303459
 ;;^UTILITY(U,$J,358.3,23175,0)
 ;;=282.49^^152^1369^104
 ;;^UTILITY(U,$J,358.3,23175,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23175,1,4,0)
 ;;=4^282.49
 ;;^UTILITY(U,$J,358.3,23175,1,5,0)
 ;;=5^Thalassemia Nec
 ;;^UTILITY(U,$J,358.3,23175,2)
 ;;=^329910
 ;;^UTILITY(U,$J,358.3,23176,0)
 ;;=289.89^^152^1369^13
 ;;^UTILITY(U,$J,358.3,23176,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23176,1,4,0)
 ;;=4^289.89
 ;;^UTILITY(U,$J,358.3,23176,1,5,0)
 ;;=5^Blood Diseases Nec
 ;;^UTILITY(U,$J,358.3,23176,2)
 ;;=^329887
 ;;^UTILITY(U,$J,358.3,23177,0)
 ;;=238.79^^152^1369^76
